Physician profile
Alan J Cox
NPI 1154305696
$13,054.16
in general payments reported to CMS, 2019-2025
35 companies · $2,581 in 2025
The $2,581 reported for 2025 was more than what 84% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $1,128 · 2021: $1,944 · 2022: $1,851 · 2023: $2,140 · 2024: $2,191 · 2025: $2,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,911.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,692.26 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $1,677.98 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Janssen Biotech, INC. | $1,610.07 | 2019-2025 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,064.48 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Pfizer INC. | $789.83 | 2019-2025 | |
| Genzyme Corporation | $547.68 | 2023-2025 | |
| Ardelyx, INC. | $521.44 | 2022-2025 | Ibsrela |
| Celgene Corporation | $483.41 | 2021-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $355.46 | 2020-2025 | Linzess |
| Regeneron Healthcare Solutions, INC. | $290.04 | 2022-2025 | Dupixent |
| Madrigal Pharmaceuticals | $289.14 | 2024-2025 | Rezdiffra, Resmetirom |
| Qol Medical, LLC | $267.07 | 2019-2025 | Sucraid, Sucraid |
| Phathom Pharmaceuticals, INC. | $266.53 | 2023-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $184.57 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $123.77 | 2019-2023 | Rebyota |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $93.30 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $89.49 | 2020-2024 | |
| Braintree Laboratories, INC. | $87.88 | 2019-2024 | Suflave |
| Boston Scientific Corporation | $83.43 | 2024-2025 | Watchman Access System, Compliance Endokit, Watchman Flx |
| Merck Sharp & Dohme LLC | $81.02 | 2021-2023 | Dificid |
| Aimmune Therapeutics, INC. | $80.51 | 2024 | |
| Ucb, INC. | $73.15 | 2019 | |
| Allergan, INC. | $48.90 | 2020 | |
| Lilly USA, LLC | $47.15 | 2025 | Omvoh |
| Amgen INC. | $36.52 | 2023 | Avsola, Amjevita |
| Nestle Healthcare Nutrition INC. | $27.75 | 2023 | |
| Albireo Pharma, INC. | $22.62 | 2024 | Bylvay |
| Daiichi Sankyo INC. | $20.67 | 2022 | |
| Novo Nordisk INC | $19.16 | 2025 | Wegovy |
| Redhill Biopharma INC. | $16.19 | 2023 | |
| Shionogi INC | $14.18 | 2019 | |
| Axonics, INC. | $14.01 | 2022 | |
| Sandoz INC. | $13.25 | 2023 | Hyrimoz |
| Medtronic, INC. | $12.87 | 2023 | Gi Genius |
| Organon LLC | $8.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.